SEARCH

SEARCH BY CITATION

References

  • 1
    European Monitoring Centre for Drugs and Drug Addiction. Annual Report 2010: The State of the Drugs Problem in Europe. Luxembourg: Publications Office of the European Union; 2010. pp. 102.
  • 2
    Beck F, Legleye S, Spilka S, Briffault X, Gautier A, Lamboy B, et al. Les niveaux d'usage des drogues en France en 2005, exploitation des données du Baromètre santé 2005. Tendances 2006, no 48, pp. 6.
  • 3
    Beck F, Guignard R, Richard JB, Tovar ML, Spilka A. Les niveaux d'usage des drogues en France en 2010. Tendances 2011, no 76, pp. 6.
  • 4
    Chassevent-Pajot A, Guillou-Landréat M, Grall-Bronnec M, Wainstein L, Philippe HJ, Lombrail P, et al. Etude de prévalence des conduites addictives chez les femmes enceintes dans une maternité universitaire. J Gynecol Obstet Biol Reprod 2011;40:23745.
  • 5
    Blondel B, Lelong N, Kermarrec M, Goffinet F. Trends in perinatal health in France from 1995 to 2010. Results from the French National Perinatal Surveys. J Gynecol Obstet Biol Reprod 2012;41:e115. Epub 2012 May 19.
  • 6
    Fergusson DM, Horwood LJ, Northstone K, ALSPAC Study Team. Maternal use of cannabis and pregnancy outcome. BJOG 2002;109:217.
  • 7
    Hayatbakhsh MR, Flenady VJ, Gibbons AM, Hurrion E, Mamun AA, Najman JM. Birth outcomes associated with cannabis use before and during pregnancy. Pediatr Res 2012;71:2159.
  • 8
    van Gelder MM, Reefhuis J, Caton AR, Werler MM, Druschel CM, Roeleveld N. the National Birth Defects Prevention Study. Drug Alcohol Depend 2010;109:2437.
  • 9
    Hatch EE, Bracken MB. Effect of marijuana use in pregnancy on fetal growth. Am J Epidemiol 1986;124:98693.
  • 10
    Fried PA, Watkinson B, Willan A. Marijuana use during pregnancy and decreased length of gestation. Am J Obstet Gynecol 1984;150:237.
  • 11
    Zuckerman B, Frank DA, Hingson R, Amaro H, Levenson SM, Kayne H, et al. N Engl J Med 1989;320:7628.
  • 12
    Ebrahim SH, Gfroerer J. Pregnancy-related substance use in the United States during 1996–1998. Obstet Gynecol 2003;101:3749.
  • 13
    Costes JM (dir.) Cannabis, données essentielles, Saint-Denis: OFDT; 2007. pp. 232.
  • 14
    Burns L, Mattick RP, Cooke M. The use of record linkage to examine illicit drug use in pregnancy. Addiction 2006;101:87382.
  • 15
    Gray TR, Eden RD, Leonard KE, Connors GJ, Shisler S, Huestis MA. Identifying prenatal cannabis exposure and effects of concurrent tobacco exposure on neonatal growth. Clin Chem 2010;56:144150.
  • 16
    Lelong N, Blondel B, Kaminski M. Evolution de la consommation de tabac des femmes pendant la grossesse en France de 1972 à 2003. J Gynecol Obstet Biol Reprod 2011;40:429.
  • 17
    Davitian C, Uzan M, Tigaizin A, Ducarme G, Dauphin H, Poncelet C. Maternal cannabis use and intra-uterine growth restriction. Gynecol Obstet Fertil 2006;34:6327.
  • 18
    El Marroun H, Tiemeier H, Steegers EAP, Roos-Hesselink JW, Jaddoe VWV, Hofman A, et al. A prospective study on intrauterine cannabis exposure and fetal blood flow. Early Hum Dev 2010;86:2316.
  • 19
    Fried PA, Watkinson B, Gray R. A follow-up study of attentional behavior in 6-year-old children exposed prenatally to marihuana, cigarettes, and alcohol. Neurotoxicol Teratol 1992;14:299311.
  • 20
    El Marroun H, Hudziak JJ, Tiemeier H, Creemers H, Steegers EAP, Jaddoe VWV, et al. Intrauterine cannabis exposure leads to more aggressive behavior and attention problems in 18-month-old girls. Drug Alcohol Depend 2011;118:4704.